PTPN22 and rheumatoid arthritis: Half of the risk of RA is thought to be genetic [1] and it has been found to be strongly associated with the major histocompatibility complex (MHC) antigen HLA-DR4 (specifically 0404 and DR0401) and the expression of genes PTPN22 and PADI4.